Pennsylvania HB2747 adds several synthetic benzimidazole-opioid substances to Schedule I of controlled substances.
Pennsylvania HB2747 amends the Controlled Substance, Drug, Device and Cosmetic Act to add several synthetic benzimidazole-opioid substances to Schedule I of controlled substances. These substances include butonitazene, etodesnitazene, flunitazene, metodesnitazene, metonitazene, N-pyrrolidino etonitazene, etonitazene, and protonitazene. The bill takes effect 60 days after enactment.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.